Europe (WHO region) vs Zambia: Reported number of people receiving antiretroviral therapy
Europe (WHO region)
2.10 million
in 2025
Zambia
1.24 million
in 2025
Europe (WHO region) rank
6th
Zambia rank
7th
Reported number of people receiving antiretroviral therapy over time
- Europe (WHO region)
- Zambia
How they compare
Europe (WHO region) currently reports 2.10 million against 1.24 million in Zambia, a difference of 855,620.
That makes Europe (WHO region)'s figure about 1.7 times Zambia's.
Across all 26 years both countries report, Europe (WHO region) has been ahead every year.
Europe (WHO region) ranks 6th and Zambia ranks 7th of 8 groups.
Europe (WHO region) has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Europe (WHO region) | Zambia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 323,000 | 86,610 | 236,390 | Europe (WHO region) |
| 2010s | 996,000 | 684,834 | 311,166 | Europe (WHO region) |
| 2020s | 1.90 million | 1.22 million | 680,752 | Europe (WHO region) |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher reported number of people receiving antiretroviral therapy, Europe (WHO region) or Zambia?
- Europe (WHO region), at 2.10 million against 1.24 million in Zambia as of 2025.
- What is the difference in reported number of people receiving antiretroviral therapy between Europe (WHO region) and Zambia?
- 855,620, with Europe (WHO region) ahead.
- How many years of comparable data are there for Europe (WHO region) and Zambia?
- 26 years are reported by both, from 2000 to 2025.
- How do Europe (WHO region) and Zambia rank globally for reported number of people receiving antiretroviral therapy?
- Europe (WHO region) ranks 6th and Zambia ranks 7th of 8 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Reported number of people receiving antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.